ImmuCell Stock

ImmuCell Assets per Share

The Total Assets per Share of ImmuCell (ICCC) as of Aug 11, 2026 is 4.70 USD. In the previous year, Total Assets per Share was 4.98 USD — a change of -5.70% (lower).

Assets per Share

4.70USD

YoY

-5.70%

Last updated:

Total Assets per Share of ImmuCell is 2026 4.70 USD. Total Assets per Share of ImmuCell was 2025 4.98 USD. It decreases by -5.70% lower compared to the previous year.
Access this data via the Eulerpool API

ImmuCell Stock analysis

What does ImmuCell do? ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImmuCell stock

Total Assets per Share of ImmuCell is 4.70 USD in 2026.

Total Assets per Share of ImmuCell changed from 4.98 USD to 4.70 USD, representing a -5.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share ImmuCell since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

Other — ImmuCell

All Key Metrics — ImmuCell